不同诱导方案配合中药治疗急性早幼粒细胞白血病临床疗效分析

来源 :中医杂志 | 被引量 : 0次 | 上传用户:dragon98141
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
急性早幼粒细胞白血病(APL)是一种具有特殊染色体t(15;17)异位形成PML-RARα融合基因的急性髓系白血病,发病急,病情进展迅速,易并发感染及弥漫性血管内凝血,早期死亡率较其他亚型急性髓系白血病高。全反式维甲酸(ATRA)和砷剂(As2O3)应用,显著提高了APL缓解率和生存率。西苑医院 Acute promyelocytic leukemia (APL) is an acute myeloid leukemia with a special chromosomal t (15; 17) that forms the PML-RARα fusion gene ectopically. The incidence of acute myeloid leukemia is very high. The disease progresses rapidly and is prone to complicated infection and disseminated intravascular Coagulation, early mortality rate than other subtypes of acute myeloid leukemia. All-trans retinoic acid (ATRA) and arsenic (As2O3) application, significantly improved APL remission rate and survival rate. Xiyuan Hospital
其他文献